Terms: = Thyroid cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Treatment
5 results:
1. PRMT5 methylating smad4 activates TGF-β signaling and promotes colorectal cancer metastasis.
Liu A; Yu C; Qiu C; Wu Q; Huang C; Li X; She X; Wan K; Liu L; Li M; Wang Z; Chen Y; Hu F; Song D; Li K; Zhao C; Deng H; Sun X; Xu F; Lai S; Luo X; Hu J; Wang G
Oncogene; 2023 May; 42(19):1572-1584. PubMed ID: 36991117
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA CATIP antisense RNA 1 (lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial-mesenchymal transition (EMT) pathway.
Qi F; Tang J; Cai Z; Wang G; Wang Z
Bioengineered; 2022 Mar; 13(3):7592-7606. PubMed ID: 35264071
[TBL] [Abstract] [Full Text] [Related]
3. Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
Liao X; Xia X; Su W; Yan H; Ma Y; Xu L; Luo H; Liu W; Yin D; Zhang WH; Chen HN; Deng Y; Ren Z; Yu Z; Liao F; Chen K; Cao M; Zhang Y; Zhang W; Wang W; Zhao JN; Xu H; Shu Y
Gynecol Oncol; 2022 Apr; 165(1):105-113. PubMed ID: 35151492
[TBL] [Abstract] [Full Text] [Related]
4. Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation.
Pan Y; Yun W; Shi B; Cui R; Liu C; Ding Z; Fan J; Jiang W; Tang J; Zheng T; Yu X; Liu Y
J Mol Endocrinol; 2020 Aug; 65(2):1-10. PubMed ID: 32302969
[TBL] [Abstract] [Full Text] [Related]
5. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.
Li T; Zhao N; Lu J; Zhu Q; Liu X; Hao F; Jiao X
Bioengineered; 2019 Dec; 10(1):282-291. PubMed ID: 31311401
[TBL] [Abstract] [Full Text] [Related]
